JBR Clinical Research For Clinical Trials

Jun 17, 2011Clinical Trial, Vaccines, Wisdom Teeth Removal

Development of innovative medicines such as new pain relief drugs or vaccines for medical conditions ranging from wisdom teeth to diabetic peripheral neuropathy is a critical part of healthcare as it helps people lead healthier and longer lives. Before a new medicine can be sold, pharmaceutical companies must perform rigorous testing through clinical trials to show that the medicine is safe and effective. Pharmaceutical companies spend millions of dollars and many years studying a single medicine. For more than 20 years, JBR Clinical Research has played an important role in this process by partnering with pharmaceutical companies to conduct the clinical trials needed to bring these medicines to market. Data quality is our specialty! The more accurate we are, the safer the vaccines and medications on the market will be.

JBR Clinical Research is Utah’s premier medical research organization that helps pharmaceutical companies by conducting clinical trials needed to determine whether a medicine is safe and effective. JBR Clinical Research services the Wasatch from Salt Lake City to Provo Utah. People who participate in a medical study may receive complementary physical exams, treatments and medication related to the study, as well as compensation for their time and travel.

Free Utah Wisdom Teeth Removal

JBR Clinical Research is the leader in wisdom teeth removal research studies. Clinical trial participants may qualify for free removal of their impacted wisdom teeth. Visit our utah wisdom teeth removal study page for more details.

Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

At CenExel Clinical Research, our top priorities are the safety and health of our patients and employees. For our Centers of Excellence to provide the highest quality of clinical research, we established and maintain a COVID-19 Task Force with representatives from every Center. The Task Force is charged with continuous monitoring of the pandemic and providing guidance and communication.

Our clinical operations continue, and we have implemented the following additional safety measures:

Enhanced screening of everyone entering any of our facilities before they are admitted into our offices or clinical areas
Reinforced internal communication regarding the COVID-19 situation, CDC and SHRM recommendations, digital team meetings, and the importance of using sick leave for anyone who has signs, symptoms, or recent exposure to someone with suspected or diagnosed COVID-19
Additional cleaning and disinfecting materials provided through our clinic and office areas
Cross-training and preparations for contingency plans if key staff need to stay home

We will continue to monitor the current situation, coordinate with the proper authorities, and update our policies and procedures as needed to ensure the safety of our patients and employees.

JBR Clinical Research For Clinical Trials

Share This Resource

​Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

Update on COVID-19